In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.
Kentucky $1.74 Million Settlement Illustrates the Danger of Billing Medicare for Nonmedical Urine Drug Tests
A recent False Claims Act settlement from Kentucky represents an unusual variation on a common theme.
The DOJ’s 2022 Fraud Statistics Overview shows it raked in less than 50 percent of what it recovered in FY 2021.
It’s not just billions of dollars on the line, but the very future of whistleblower lawsuits and FCA enforcement.
The bipartisan bill was recently reintroduced to amend the FCA in response to a landmark 2016 Supreme Court ruling.